Abbott Laboratories (ABT) Shares Outstanding (2009 - 2026)

Abbott Laboratories has disclosed Shares Outstanding (Entity) across 18 years of filings, most recently posting $1.7 billion for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) fell 0.58% year-over-year to $1.7 billion; the TTM figure through Jun 2026 stood at $1.7 billion (down 0.58% YoY), while the FY2025 annual figure was $1.7 billion, changed 0.19% from the prior year.
• Shares Outstanding (Entity) came in at $1.7 billion for Q2 2026 at Abbott Laboratories, down from $1.7 billion in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $1.8 billion in Q2 2022 to a low of $1.7 billion in Q2 2026.
• Average Shares Outstanding (Entity) over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2023.
• Year-over-year, Shares Outstanding (Entity) declined 1.46% in 2022 and increased 0.26% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $1.7 billion in 2022, then decreased by 0.16% to $1.7 billion in 2023, then slipped by 0.05% to $1.7 billion in 2024, then advanced by 0.19% to $1.7 billion in 2025, then slipped by 0.42% to $1.7 billion in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $1.7 billion in Q2 2026, $1.7 billion in Q1 2026, and $1.7 billion in Q4 2025.